Many aberrations picked up on lung cancer screens are harmless and benign, but a dangerous few are not. Now, robotic ...

Results of a new study conclude that a pathology tool powered by artificial intelligence can predict whether a patient with ...

Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer ...

Abenacianine, a fluorescent imaging agent, received FDA fast track status for enhancing tumor visualization during lung cancer surgery, showing safety and efficacy in phase 2 trials. Alecensa ...

Lung cancer in never-smokers exhibits distinct biological characteristics, often leading to late-stage diagnoses due to lack of screening. Targeted therapies, guided by molecular testing, offer ...

LOS ANGELES — An LA mom became one of the first patients in Southern California to try a new targeted lung cancer therapy. Now 41, Heather Suchan received the news that would completely change her ...

During its March 2026 meeting, the agency’s Committee for Medicinal Products for Human Use approved treatments for Bacillus ...

Published in Cancer Discovery, early trials show that sevabertinib can shrink tumours in patients with HER2 exon 20, a ...

Doctors should not automatically rule out surgery for octogenarians with early-stage lung cancer, according to a new study ...

Cancer survival might depend on what time of day you get your treatment, a new study says. Lung cancer patients who received IV immunotherapy doses earlier in the day tended to live longer, ...

Immunotherapy is a cancer treatment that harnesses the body’s immune system to fight cancer. It helps the immune system recognize and attack cancer cells, which can sometimes be hidden from the body’s ...